Chapter 011

Introduction to Central Nervous System Drugs1

Vahn A. Lewis

CITED REFERENCES

  1. Akil H, Watson SJ, Young E, et al: Endogenous opioids: biology and function. Annu Rev Neurosci 7:223-255, 1984. PUBMED Abstract
  2. Angst MS, Bührer M, Lötsch J: Insidious intoxication after morphine treatment in renal failure: delayed onset of morphine-6-glucuronide action. Anesthesiology 92:1473-1476, 2000.
  3. Avila J, Lucas JJ, Perez M, et al: Role of tau protein in both physiological and pathological conditions. Physiol Rev 84:361-384, 2004. PUBMED Abstract
  4. Basu S, Alavi A: Unparalleled contribution of 18F-FDG PET to medicine over 3 decades. J Nucl Med 49:17N-21N, 37N, 2008. PUBMED Abstract
  5. Baumgartner U, Buchholz HG, Bellosevich A, et al: High opiate receptor binding potential in the human lateral pain system. Neuroimage 30:692-699, 2006. PUBMED Abstract
  6. Beck P, Odle A, Wallace-Huitt T, et al: Modafinil increases arousal determined by P13 potential amplitude: an effect blocked by gap junction antagonists. Sleep 31:1647-1654, 2008. PUBMED Abstract
  7. Bimar J, Bellville JW: Arousal reactions during anesthesia in man. Anesthesiology 47:449-454, 1977. PUBMED Abstract
  8. Birzniece V, Bäckström T, Johansson IM, et al: Neuroactive steroid effects on cognitive functions with a focus on the serotonin and GABA systems. Brain Res Rev 51:212-239, 2006. PUBMED Abstract
  9. Bodnar RJ: Endogenous opiates and behavior: 2007. Peptides 29:2292-2375, 2008. PUBMED Abstract
  10. Boroujerdi A, Kim HK, Lyu YS, et al: Injury discharges regulate calcium channel alpha-2-delta-1 subunit upregulation in the dorsal horn that contributes to initiation of neuropathic pain. Pain 139:358-366, 2008.
  11. Brown GC: Mechanisms of inflammatory neurodegeneration: iNOS and NADPH oxidase. Biochem Soc Trans 35(Pt 5):1119-1121, 2007. PUBMED Abstract
  12. Chang L, Haning W: Insights from recent positron emission tomographic studies of drug abuse and dependence. Curr Opin Psychiatry 19:246-252, 2006. PUBMED Abstract
  13. Cooper JR, Bloom FE, Roth RH: The biochemical basis of neuropharmacology, ed 7, New York, 1996, Oxford University Press.
  14. Cooper JR, Meyer EM: Possible mechanisms involved in the release or modulation of release of neuroactive agents. Neurochem Int 6:419-427, 1984. PUBMED Abstract
  15. Cutajar MC, Edwards TM: Evidence for the role of endogenous carbon monoxide in memory processing. J Cogn Neurosci 19:557-562, 2007. PUBMED Abstract
  16. Diefenbach RJ, Miranda-Saksena M, Douglas MW, et al: Transport and egress of herpes simplex virus in neurons. Rev Med Virol 18:35-51, 2008. PUBMED Abstract
  17. Domek-Lopacinska K, Strosznajder JB: Cyclic GMP metabolism and its role in brain physiology. J Physiol Pharmacol 56(Suppl 2):15-34, 2005. PUBMED Abstract
  18. Fagg GE, Foster AC: Amino acid neurotransmitters and their pathways in the mammalian central nervous system. Neuroscience 9: 701-719, 1983. PUBMED Abstract
  19. Fisher HE, Aron A, Brown LL: Romantic love: a mammalian brain system for mate choice. Philos Trans R Soc Lond B Biol Sci 361:2173-2186, 2006. PUBMED Abstract
  20. Garcia-Rill E, Heister DS, Ye M, et al: Electrical coupling: novel mechanism for sleep-wake control. Sleep 30:1405-1414, 2007. PUBMED Abstract
  21. Groneberg DA, Fischer TC, Peckenschneider N, et al: Cell type-specific regulation of brain-derived neurotrophic factor in states of allergic inflammation. Clin Exp Allergy 37:1386-1391, 2007. PUBMED Abstract
  22. Judas M, Sestan N, Kostovic I: Nitrinergic neurons in the developing and adult human telencephalon: transient and permanent patterns of expression in comparison to other mammals. Microsc Res Tech 45:401-419, 1999. PUBMED Abstract
  23. Kandel ER, Shwartz JH, Jessell TM, editors: Principles of neural science, ed 4, New York, 2000, McGraw-Hill.
  24. Krasowski MD, Harrison NL: General anaesthetic actions on ligand-gated ion channels. Cell Mol Life Sci 55:1278-1303,1999. PUBMED Abstract
  25. Langston JW: MPTP neurotoxicity: an overview and characterization of phases of toxicity. Life Sci 36:201-206, 1985. PUBMED Abstract
  26. Lauria G, Morbin M, Lombardi R, et al: Expression of capsaicin receptor immunoreactivity in human peripheral nervous system and in painful neuropathies. J Peripher Nerv Syst 11:262-271, 2006. PUBMED Abstract
  27. Lee TS, Mane S, Eid T, et al: Gene expression in temporal lobe epilepsy is consistent with release of glutamate by astrocytes. Mol Med 13:1-13, 2007. PUBMED Abstract
  28. Leonard BE: Inflammation, depression and dementia: are they connected? Neurochem Res 32:1749-1756, 2007. PUBMED Abstract
  29. Levine RR: Pharmacology: drug actions and reactions, ed 6, Boston, 2000, Little, Brown.
  30. Levitan IB, Kaczmarek LK: The neuron: cell and molecular biology, ed 3, New York, 2002, Oxford University Press.
  31. Liebman M: Neuroanatomy made easy and understandable, ed 4, Rockville, MD, 1991, Aspen.
  32. Loring JF: Evolution of microarray analysis. Neurobiol Aging 27:1084-1086, 2006. PUBMED Abstract
  33. Malhi GS, Lagopoulos J: Making sense of neuroimaging in psychiatry. Acta Psychiatr Scand 117:100-117, 2008. PUBMED Abstract
  34. Malsam J, Kreye S, Söllner TH: Membrane fusion: SNAREs and regulation. Cell Mol Life Sci 65:2814-2832, 2008. PUBMED Abstract
  35. McCann SM: The nitric oxide hypothesis of brain aging. Exp Gerontol 32:431-440, 1997. PUBMED Abstract
  36. Mousa SH, Cheppudira BP, Shaqura M, et al: Nerve growth factor governs the enhanced ability of opioids to suppress inflammatory pain. Brain 130:502-513, 2007. PUBMED Abstract
  37. Narayan S, Head SR, Gilmartin TJ, et al: Evidence for disruption of sphingolipid metabolism in schizophrenia. J Neurosci Res 87:278-288, 2009. PUBMED Abstract
  38. Olsen RW, Sieghart W: GABA(A) receptors: subtypes provide diversity of function and pharmacology. Neuropharmacology 56:141-148, 2009. PUBMED Abstract
  39. Orr JD: Statins in the spectrum of neurologic disease. Curr Atheroscler Rep 10:11-18, 2008. PUBMED Abstract
  40. Penfield W, Rasmussen T: The cerebral cortex of man: a clinical study of localization of function. New York, 1950, Macmillan.
  41. Pfleiderer B, Zinkirciran S, Arolt V, et al: fMRI amygdala activation during a spontaneous panic attack in a patient with panic disorder. World J Biol Psychiatry 8:269-272, 2007. PUBMED Abstract
  42. Qu K, Lee SW, Bian JS, et al: Hydrogen sulfide: neurochemistry and neurobiology. Neurochem Int 52:155-165, 2008. PUBMED Abstract
  43. Rang H, Bevan S, Dray A: Nociceptive peripheral nerves: cellular properties. In Wall PD, Melzack R, editors: Textbook of pain, ed 4, New York, 1994, Churchill Livingstone.
  44. Reynolds A, Bartletta S, Hendrya I: Molecular mechanisms regulating the retrograde axonal transport of neurotrophins. Brain Res Rev 33:169-178, 2000. PUBMED Abstract
  45. Ross RA: Allosterism and cannabinoid CB(1) receptors: the shape of things to come. Trends Pharmacol Sci 28:567-572, 2007. PUBMED Abstract
  46. Savic I, Widen L, Thorell JO, et al: Cortical benzodiazepine receptor binding in patients with generalized and partial epilepsy. Epilepsia 31:724-730, 1990. PUBMED Abstract
  47. Schlicker E, Kathmann M: Modulation of transmitter release via presynaptic cannabinoid receptors. Trends Pharmacol Sci 22:565-572, 2001. PUBMED Abstract
  48. Schousboe A, Sarup A, Bak LK, et al: Role of astrocytic transport processes in glutamatergic and GABAergic neurotransmission. Neurochem Int 45:521-527, 2004. PUBMED Abstract
  49. Shibasaki H: Human brain mapping: hemodynamic response and electrophysiology. Clin Neurophysiol 119:731-743, 2008. PUBMED Abstract
  50. Sieghart W: GABA A receptors: ligand-gated Cl- ion channels modulated by multiple drug-binding sites. Trends Pharmacol Sci 13:446-450, 1992. PUBMED Abstract
  51. Söhl G, Maxeiner S, Willecke K: Expression and functions of neuronal gap junctions, Nat Rev Neurosci 6:191-200, 2005. PUBMED Abstract
  52. Stepien K, Tomaszewski M, Czuczwar SJ: Neuroprotective properties of statins. Pharmacol Rep 57:561-569, 2005. PUBMED Abstract
  53. Südhof TC, Rothman JE: Membrane fusion: grappling with SNARE and SM proteins. Science 323:474-477, 2009. PUBMED Abstract
  54. Szolcsányi J: Forty years in capsaicin research for sensory pharmacology and physiology. Neuropeptides 38:377-384, 2004. PUBMED Abstract
  55. Varrone A, Marek KL, Jennings D, et al: [(123)I)]-CIT SPECT imaging demonstrates reduced density of striatal dopamine transporters in Parkinson’s disease and multiple system atrophy. Mov Disord 16:1023-1032, 2001. PUBMED Abstract
  56. von Kriegstein K, Schmitz F: The expression pattern and assembly profile of synaptic membrane proteins in ribbon synapses of the developing mouse retina. Cell Tissue Res 311:159-173, 2003. PUBMED Abstract
  57. Yang H, Chen CL: Cycloxygenase-2 in synaptic signaling. Curr Pharm Des 14:1443-1451, 2008. PUBMED Abstract

GENERAL REFERENCES

  1. Alberts B, Bray D, Lewis J, et al: Molecular biology of the cell, ed 4, New York, 2002, Garland.
  2. Banerjee S, Bhat MA: Neuron-glial interactions in blood-brain barrier formation, Ann Rev Neurosci 30:235-258, 2007. PUBMED Abstract
  3. Harmar AJ, Hills RA, Rosser EM, et al: IUPHAR database of G protein–coupled receptors and ion channels. Nucl Acid Res 37(Database issue): D680-D685, 2009. Available at: http://www.iuphar-db.org/index.isp. Accessed December 10, 2009. PUBMED Abstract
  4. Iversen L, Iversen S, Bloom FE, et al: Introduction to neuropsychopharmacology, New York, 2009, Oxford University Press.
  5. Kandel ER, Schwartz JH, Jessell TM: Principles of neural science, New York, 2000, McGraw Hill.
  6. Nestler E, Hyman S, Malenka R: Molecular basis of neuropharmacology: a foundation for clinical neuroscience, New York, 2009, McGraw Hill.
  7. Raichle M, Mintun M: Brain work and brain imaging, Ann Rev Neurosci 29:449-476, 2006.
  8. Wall PD, Melzack R, editors: Textbook of pain, ed 3, New York, 1994, Churchill Livingstone.

1The author wishes to recognize Drs. Kenneth M. Hargreaves, Douglass L. Jackson, and Mark T. Roszkowski for their past contributions to this chapter.